Pretty good quarterly result IMO.
It’s a shame they don’t split the trial cost out…
Either way, and improved cash burn which is encouraging given there would have been increased activity in both the Burkina Faso and Ghana trial sites, especially in the Ghana site which would have had its busiest period as the site got going and the clinical audit took place
Good stuff EMS.
Pretty good quarterly result IMO.It’s a shame they don’t split...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
